# EVRYSDI
> **NDA219285** · New Drug Application · Sponsor: GENENTECH INC · Approved 2025-02-11
## Drug
- **FDA Application Number:** NDA219285
- **Application type:** New Drug Application
- **Brand name:** EVRYSDI
- **Generic name:** RISDIPLAM
- **Active ingredients:** RISDIPLAM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH INC
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2025-02-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219285)
---
*AI Analytics · CC0 1.0*